Latest news with #Procter&GambleHealth
&w=3840&q=100)
Business Standard
01-08-2025
- Business
- Business Standard
Procter & Gamble Health rallies 10%, hits 4-year high on strong Q1 results
Procter & Gamble Health share price today Shares of Procter & Gamble Health hit a four-year high at ₹6,475, as they rallied 10 per cent on the BSE in Friday's intra-day trade in an otherwise weak market after the company reported strong earnings for the quarter ended June 2025 (Q1FY26). The stock price of the pharmaceutical company was quoting at its lowest level since April 2021. It had hit a record high of ₹7,499.95 on February 11, 2021. At 02:34 PM; Procter & Gamble Health was trading 7 per cent higher at ₹6,312.10, as compared to 0.40 per cent decline in the BSE Sensex. Q1 results - Procter & Gamble Health Procter & Gamble Health delivered a strong performance with sales of ₹333 crore, up 20 per cent against a year ago, owing to broad-based growth in domestic and exports business. Profit after tax (PAT) stood at ₹66 crore, against ₹17 crore a year ago, due to strong sales growth and one-time impact of impairment in the base period. Commenting on the performance, Milind Thatte, Managing Director, P&G Health India, said, "We are pleased with the continued momentum and strong start to the Financial Year 2025-26. These results are a reflection of our commitment towards addressing the evolving needs of our consumers and healthcare professionals, via superior brand building and go to market initiatives while improving supply chain capabilities'. The company's strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results, Milind Thatte said. Opportunities, outlook The healthcare sector in India has undergone a significant transformation, fueled by substantial investments in infrastructural development. Since 2016, the Indian healthcare industry has witnessed a consistent growth trajectory. The consumer healthcare sector shows promising prospects for the future. The company is well-positioned to sustain and strengthen its position in the market. About Procter & Gamble Health Procter & Gamble Health Limited is one of India's largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Ambi Pur, Ariel, Gillette, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide, Vicks, and Whisper. P&G operates in approximately 70 countries worldwide.
Business Upturn
01-08-2025
- Business
- Business Upturn
P&G Health shares surge 8% as Q1 revenue jumps 19.5% YoY to Rs 339 crore
Shares of Procter & Gamble Health surged over 8% on Friday following the company's robust financial performance in the first quarter of FY26. The stock touched a high of ₹6,476, rising sharply from the previous close of ₹5,895.50. As of 2:12 PM, the shares were trading 7.97% higher at Rs 6,365.50. P&G Health reported a massive jump in net profit, which stood at ₹66.2 crore, up from ₹16.8 crore in the same quarter last year. Revenue for the quarter rose 19.5% year-on-year to ₹339 crore, compared to ₹283.8 crore in Q1FY25. The company's EBITDA also witnessed strong growth, rising 89% to ₹90.5 crore from ₹48.2 crore last year. Operating margins expanded to 26.7%, a significant improvement from 17% in the year-ago period. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
